This text is a result of machine translation.
Tiger pharmaceutical performance forecast: net profit in 2020 will increase by 100% - 115% year on year
Junshi biology announced that anti tigit monoclonal antibody js006 injection was approved for clinical trial.
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Tiankang biological performance forecast: net profit in 2020 increased by 160.67% - 179.29% year on year
Dongcheng pharmaceutical: at present, the market price of heparin API is about US $80-90 / Mega, and there is still room for increase
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Hot landscape: net profit will increase by about 216% in 2020
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
With a daily detection flux of 1 million, Huada Zhizao automatic nucleic acid extraction and purification instrument helps Hebei epidemic prevention and control
Xinqing medical, a domestic artificial heart and lung device enterprise, won the B round financing of over 100 million yuan from Aurora Borealis venture capital
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Focus on high-throughput single-cell omics platform products, search for a reason to complete more than 100 million yuan round a financing
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Sinopharm new coronavirus vaccine approved
Another protein component special medical food was approved, and the total number of approved products increased to 57
TAL's Positive Growth in a Highly Competitive Industry
yesterday 10:50 AM